Canadian oncogenic human papillomavirus cervical infection prevalence: Systematic review and meta-analysis
Open Access
- 5 September 2011
- journal article
- review article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 11 (1) , 235
Abstract
Oncogenic human papillomavirus (HPV) infection prevalence is required to determine optimal vaccination strategies. We systematically reviewed the prevalence of oncogenic cervical HPV infection among Canadian females prior to immunization.Keywords
This publication has 84 references indexed in Scilit:
- Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in EnglandBritish Journal of Cancer, 2010
- Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women—implications for vaccinationCancer Causes & Control, 2009
- A review of human carcinogens—Part B: biological agentsThe Lancet Oncology, 2009
- The Association of Obesity and Cervical Cancer Screening: A Systematic Review and Meta‐analysisObesity, 2009
- Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis updateInternational Journal of Cancer, 2007
- Overview of the European and North American studies on HPV testing in primary cervical cancer screeningInternational Journal of Cancer, 2006
- Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysisBritish Journal of Cancer, 2003
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysisBritish Journal of Cancer, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986